{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-135399","form_type":"8-K","ticker":"PSTV","cik":"0001095981","company_name":"PLUS THERAPEUTICS, INC.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.263433+00:00","generated_at":"2026-06-02T04:49:42.439490+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"PSTV raises $7.25M via private placement of shares and warrants","bullets":["Gross proceeds of $7.25M from private placement of 3,591,532 units at $2.022/$2.158 per unit.","Units consist of one share (or pre-funded warrant) plus Series A and Series B warrants.","Series A warrants exercisable for 5 years, Series B warrants exercisable for 1 year after registration effectiveness.","Potential additional proceeds up to $12M from warrant exercises.","Insiders purchased $98,500 of securities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-135399","json":"https://secwatch.observer/filing/0001193125-24-135399.json","markdown":"https://secwatch.observer/filing/0001193125-24-135399.md","text":"https://secwatch.observer/filing/0001193125-24-135399.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524135399/0001193125-24-135399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524135399/d827838d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T04:49:42.439490+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f54836305ac188383b3a3f0c27869c82d2825e6","claim":"PLUS THERAPEUTICS, INC. entered into Securities Purchase Agreement with certain investors identified on the signature page thereto (collectively, the \"Purchasers\") valued at approximately $6.5 million (effective 2024-05-05).","evidence_excerpt":"On May 5, 2024, Plus Therapeutics, Inc. (the “Company”) entered into a securities purchase agreement (the “Securities Purchase Agreement”) with certain investors identified on the signature page thereto (collectively, the “Purchasers”) for a private placement of securities (the “Initial Subscription”) for gross proceeds at the Closing Date (as defined below) of approximately $6.5 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524135399/0001193125-24-135399-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors identified on the signature page thereto (collectively, the \"Purchasers\")"},{"label":"Value","value":"approximately $6.5 million"},{"label":"Effective","value":"2024-05-05"}],"fact_type":"material_agreement"},{"claim_id":"137d72af710d12fe5849ee0abbaa0b344caca24e","claim":"PLUS THERAPEUTICS, INC. amended Securities Purchase Agreement with certain investors identified on the signature page thereto (collectively, the \"Purchasers\") valued at approximately $0.75 million (effective 2024-05-08).","evidence_excerpt":"On May 8, 2024, the Company entered into an amendment to the Securities Purchase Agreement (the “Amendment”) that increased the aggregate subscription amount by approximately $0.75 million (the “Additional Subscription”) for aggregate initial gross proceeds of approximately $7.25 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1095981/000119312524135399/0001193125-24-135399-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors identified on the signature page thereto (collectively, the \"Purchasers\")"},{"label":"Value","value":"approximately $0.75 million"},{"label":"Effective","value":"2024-05-08"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}